Pharmaceuticals, Biotechnology and Life Sciences
Johnson & Johnson has Announced BARDA Funding Award to Accelerate Ebola Vaccine Program Prime-boost vaccine regimen in development at the…
Hikma Pharmaceuticals PLC, a multinational pharmaceutical group, has agreed to acquire 98.09% of the share capital of EIMC United Pharmaceuticals (EUP)…
Takeda Pharmaceutical Company Limited will participate in WIPO Re:Search, a consortium to accelerate research and development (R&D) of new drugs, vaccines,…
The European Commission has approved the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) for the treatment of adult patients with…
Alexion Pharmaceuticals, Inc. announced on September 1, 2015, that the European Commission has approved Strensiq (asfotase alfa) for long-term enzyme replacement…
The National Institute on Drug Abuse (NIDA) has announced that Adapt Pharma Limited, a partner of Lightlake Therapeutics Inc., has started a rolling…
Cosentyx (secukinumab) met the primary endpoints of superiority compared to placebo in patients with difficult-to-treat psoriasis of the nails, palms…
Novartis announced data that show majority of patients with polycythemia vera treated with Jakavi achieved long-term disease control. The company said…
Novartis reports new analysis showing Xolair® improving quality of life by 78% for chronic spontaneous urticaria patients New analysis from…